The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
News Post List
Cancer Research UK is making difficult decisions to significantly reduce how much it spends on beating cancer, its operations and the number of staff.
We’re having to scale down our work to reflect our new situation, but our ambition remains the same, writes our chief executive, Michelle Mitchell.
The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer...
News digest – light-activated nanoparticles, Government’s obesity plans, tumour ‘glue’ and AI research fund
Researchers are developing light-activated nanoparticles that can ‘rob’ cancer cells of vital survival proteins.
The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.
Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic.
We caught up with a number of researchers about how COVID-19 has impacted their work, and what the next few months looks like for them.
Our scientists have uncovered more about the naked mole-rat's resistance to cancer.
Naked mole-rats' exceptional resistance to cancer is thanks to unique conditions in their bodies that stop cancer cells multiplying, according to new research.